ARTICLE I
DEFINITIONS
As used in these Bylaws, unless the context otherwise requires, the term:
1.1. “Board” means the Board of Directors of the Corporation.
1.2. “Bylaws” means these Bylaws of the Corporation, as amended from time to time.
1.3. “Certificate of Incorporation” means the Certificate of Incorporation of the Corporation, as amended from time to time.
1.4. “Corporation” means NGM Biopharmaceuticals, Inc.
1.5. “DGCL” means the General Corporation Law of the State of Delaware, as amended from time to time.
1.6. “Directors” means the directors of the Corporation.
1.7. “law” means any U.S. or non-U.S., federal, state or local law (statutory, common or otherwise), constitution, treaty, convention, ordinance, code, rule, regulation, order, injunction, judgment, decree, ruling or other similar requirement enacted, adopted, promulgated or applied by a governmental authority (including any department, court, agency or official, or non-governmental self-regulatory organization, agency or authority and any political subdivision or instrumentality thereof).
1.8. “Office of the Corporation” means the principal executive office of the Corporation, the Corporation’s registered office in the State of Delaware or any other offices at any other place or places designated from time to time by the Board as an Office of the Corporation for purposes of these Bylaws.
1.9. “President” means the President of the Corporation.
1.10. “Secretary” means the Secretary of the Corporation.
1.11. “Stockholders” means the stockholders of the Corporation as set forth on its stock ledger.
1.12. “Treasurer” means the Treasurer of the Corporation.
1.13. “Vice President” means a Vice President of the Corporation.